Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/1b, clinical study of IVX-121 as a potential vaccine for respiratory syncytial virus (RSV) in healthy adults, including older adults

Next Previous
X
Search
Trial Profile

A Phase 1/1b, clinical study of IVX-121 as a potential vaccine for respiratory syncytial virus (RSV) in healthy adults, including older adults

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs IVX-121 (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions; First in man
  • Sponsors Icosavax

    • Most Recent Events

    • 08 Aug 2023 Results from Phase 1b extension 12-month immunogenicity and Phase 1b extension trial revaccination data presented in an Icosavax media release.
    • 13 Dec 2022 According to an Icosavax media release, the company intends to present additional data at a future medical meeting.
    • 13 Dec 2022 Six-month immunogenicity data published in an Icosavax Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top